Tea flavonols in cardiovascular disease and cancer epidemiology

被引:130
作者
Hollman, PCH
Feskens, EJM
Katan, MB
机构
[1] State Inst Qual Control Agr Prod, RIKILT DLO, NL-6708 PD Wageningen, Netherlands
[2] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands
[3] Wageningen Ctr Food Sci, NL-6703 HD Wageningen, Netherlands
[4] Agr Univ Wageningen, Dept Human Nutr & Epidemiol, NL-6703 HD Wageningen, Netherlands
来源
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE | 1999年 / 220卷 / 04期
关键词
D O I
10.1046/j.1525-1373.1999.d01-33.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tea is an important dietary source of flavonols in countries such as the Netherlands, the United Kingdom end Japan. Flavonols may have beneficial health effects because of their antioxidant properties and their inhibitory role in various stages of tumor development in animal studies, The association between flavonol intake and cancer risk was investigated in three prospective studies (Zutphen Elderly Study in the Netherlands, a Finnish cohort, and the Netherlands Cohort Study), Only one study (Finnish cohort) showed an inverse association with cancer mortality, The intake of flavonols with subsequent cardiovascular disease was studied in six prospective epidemiological studies, In some populations (Seven Countries Study, Zutphen Elderly Study, a Finnish cohort) a clear protective effect was observed, In a large US cohort, a protective effect was only found in a subgroup with previous history of coronary heart disease, whereas in Welsh men, flavonol intake, mainly from tea, was associated with an increased risk of coronary heart disease. These conflicting results may be due to confounding by coronary risk factors associated with tea consumption. The question of whether flavonols protect against cardiovascular disease remains still open; a protective effect of flavonols against cancer is less likely.
引用
收藏
页码:198 / 202
页数:5
相关论文
共 29 条
[1]   PATIENTS WITH EARLY-ONSET PERIPHERAL VASCULAR-DISEASE HAVE INCREASED LEVELS OF AUTOANTIBODIES AGAINST OXIDIZED LDL [J].
BERGMARK, C ;
WU, R ;
DEFAIRE, U ;
LEFVERT, AK ;
SWEDENBORG, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (04) :441-445
[2]   FLAVONOIDS INHIBIT THE OXIDATIVE MODIFICATION OF LOW-DENSITY LIPOPROTEINS BY MACROPHAGES [J].
DEWHALLEY, CV ;
RANKIN, SM ;
HOULT, JRS ;
JESSUP, W ;
LEAKE, DS .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (11) :1743-1750
[3]  
GOLDBOHM RA, 1995, AM J EPIDEMIOL, V141, pS61
[4]   FREE-RADICALS, ANTIOXIDANTS, AND HUMAN-DISEASE - CURIOSITY, CAUSE, OR CONSEQUENCE [J].
HALLIWELL, B .
LANCET, 1994, 344 (8924) :721-724
[5]   DIETARY FLAVONOIDS AND CANCER RISK IN THE ZUTPHEN ELDERLY STUDY [J].
HERTOG, MGL ;
FESKENS, EJM ;
HOLLMAN, PCH ;
KATAN, MB ;
KROMHOUT, D .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1994, 22 (02) :175-184
[6]   INTAKE OF POTENTIALLY ANTICARCINOGENIC FLAVONOIDS AND THEIR DETERMINANTS IN ADULTS IN THE NETHERLANDS [J].
HERTOG, MGL ;
HOLLMAN, PCH ;
KATAN, MB ;
KROMHOUT, D .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1993, 20 (01) :21-29
[7]   FLAVONOID INTAKE AND LONG-TERM RISK OF CORONARY-HEART-DISEASE AND CANCER IN THE 7 COUNTRIES STUDY [J].
HERTOG, MGL ;
KROMHOUT, D ;
ARAVANIS, C ;
BLACKBURN, H ;
BUZINA, R ;
FIDANZA, F ;
GIAMPAOLI, S ;
JANSEN, A ;
MENOTTI, A ;
NEDELJKOVIC, S ;
PEKKARINEN, M ;
SIMIC, BS ;
TOSHIMA, H ;
FESKENS, EJM ;
HOLLMAN, PCH ;
KATAN, MB .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (04) :381-386
[8]   DIETARY ANTIOXIDANT FLAVONOIDS AND RISK OF CORONARY HEART-DISEASE - THE ZUTPHEN ELDERLY STUDY [J].
HERTOG, MGL ;
FESKENS, EJM ;
HOLLMAN, PCH ;
KATAN, MB ;
KROMHOUT, D .
LANCET, 1993, 342 (8878) :1007-1011
[9]   Antioxidant flavonols and ischemic heart disease in a Welsh population of men: The Caerphilly Study [J].
Hertog, MGL ;
Sweetman, PM ;
Fehily, AM ;
Elwood, PC ;
Kromhout, D .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (05) :1489-1494
[10]   Antioxidant flavonols and coronary heart disease risk [J].
Hertog, MGL ;
Feskens, EJM ;
Kromhout, D .
LANCET, 1997, 349 (9053) :699-699